GLICLAVAC M

GLICLAVAC M is a combination oral antidiabetic medication containing Gliclazide 80 mg and Metformin 500 mg, designed for the management of type 2 diabetes mellitus. Gliclazide, a sulfonylurea, helps stimulate insulin release from the pancreas, while Metformin improves insulin sensitivity and reduces glucose production in the liver. Together, they help control blood sugar levels effectively.

Key Benefits:

• Helps lower and maintain blood glucose levels.

• Combines two mechanisms for better diabetes control.

• Supports overall diabetes management along with diet and lifestyle modifications.